121 related articles for article (PubMed ID: 31846064)
1. Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.
Ersvaer E; Hveem TS; Vlatkovic L; Brennhovd B; Kleppe A; Tobin KAR; Pradhan M; Cyll K; Waehre H; Kerr DJ; Danielsen HE
Int J Cancer; 2020 Aug; 147(4):1228-1234. PubMed ID: 31846064
[TBL] [Abstract][Full Text] [Related]
2. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
3. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of p53 and DNA ploidy following radical prostatectomy.
Deliveliotis C; Skolarikos A; Karayannis A; Tzelepis V; Trakas N; Alargof E; Protogerou V
World J Urol; 2003 Aug; 21(3):171-6. PubMed ID: 12844233
[TBL] [Abstract][Full Text] [Related]
6. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
7. Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer.
Lexander H; Palmberg C; Hellman U; Auer G; Hellström M; Franzén B; Jörnvall H; Egevad L
Proteomics; 2006 Aug; 6(15):4370-80. PubMed ID: 16888723
[TBL] [Abstract][Full Text] [Related]
8. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
[TBL] [Abstract][Full Text] [Related]
9. [Influence of DNA ploidy and grading on survival in primary metastatic prostate carcinoma].
Kugler A; Gross AJ; Zöller G; Hemmerlein B; Kallerhoff M; Ringert RH
Urologe A; 1997 Mar; 36(2):138-42. PubMed ID: 9199041
[TBL] [Abstract][Full Text] [Related]
10. Tumour heterogeneity poses a significant challenge to cancer biomarker research.
Cyll K; Ersvær E; Vlatkovic L; Pradhan M; Kildal W; Avranden Kjær M; Kleppe A; Hveem TS; Carlsen B; Gill S; Löffeler S; Haug ES; Wæhre H; Sooriakumaran P; Danielsen HE
Br J Cancer; 2017 Jul; 117(3):367-375. PubMed ID: 28618431
[TBL] [Abstract][Full Text] [Related]
11. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
[TBL] [Abstract][Full Text] [Related]
12. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
Pollack A; Zagars GK; el-Naggar AK; Terry NH
Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
[TBL] [Abstract][Full Text] [Related]
13. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry.
So MJ; Cheville JC; Katzmann JA; Riehle DL; Lohse CM; Pankratz VS; Sebo TJ
Mod Pathol; 2001 Sep; 14(9):906-12. PubMed ID: 11557788
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
16. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
18. Large scale genomic instability as an additive prognostic marker in early prostate cancer.
Pretorius ME; Waehre H; Abeler VM; Davidson B; Vlatkovic L; Lothe RA; Giercksky KE; Danielsen HE
Cell Oncol; 2009; 31(4):251-9. PubMed ID: 19633362
[TBL] [Abstract][Full Text] [Related]
19. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
[TBL] [Abstract][Full Text] [Related]
20. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate.
Voges GE; Eigner EB; Ross W; Sussman H; Stöckle M; Freiha FS; Stamey TA
Eur Urol; 1993; 24(1):132-9. PubMed ID: 8365433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
